0.008853
0.000000
0.002347
0.000000
0.025969
0.000000
0.000000
0.000000
0.011634
0.00000
0.00000
0.00000
Abrahams, J.P.
Elliott, P.R.
Lomas, D.A.
Carrell, R.W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
104.85
90.00
112.958
38.508
88.928
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C5 H11 N O2 S2
181.276
n
3-(ethyldisulfanyl)-L-alanine
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
3
676
681
10.1038/nsb0896-676
8756325
Inhibitory conformation of the reactive loop of alpha 1-antitrypsin.
1996
10.2210/pdb1psi/pdb
pdb_00001psi
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
NICKEL COATED DOUBLE MIRROR
IMAGE PLATE
1996-02-12
MARRESEARCH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
ELLIOTT GX-11
44406.539
ALPHA=1=-ANTITRYPSIN
F51L
1
man
polymer
no
yes
MDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNILFSPVSIATAFAMLSLGTKADTHDEILEGL
NFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDY
VEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQH(SCS)KKLS
SWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGA
DLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK
MDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNILFSPVSIATAFAMLSLGTKADTHDEILEGL
NFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDY
VEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVL
LMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSG
VTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
BLOOD PLASMA
Escherichia
sample
ALPHA-1-ANTITRYPSIN
9606
BLOOD
Homo sapiens
ALPHA-1-ANTITRYPSIN
562
Escherichia coli
PTERMAT
1
2.11
45.00
6.0
24% PEG, 0.2 M SODIUM ACETATE, 0.1 M TRIS.HCL, PH 6.0, 0.002 M FESO4, 25 DEG CELSIUS
database_2
pdbx_database_status
struct_conn
struct_ref_seq_dif
struct_sheet
pdbx_initial_refinement_model
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
Refinement description
1
0
1996-12-07
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
1
4
2023-08-09
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
_struct_sheet.number_strands
Y
BNL
1996-06-11
REL
REL
9API
CLEAVED ALPHA1-ANTITRYPSIN (PDB ENTRY 9API)
PDB
experimental model
n
1
1
A
n
2
2
A
n
3
3
A
n
4
4
A
n
5
5
A
n
6
6
A
n
7
7
A
n
8
8
A
n
9
9
A
n
10
10
A
n
11
11
A
n
12
12
A
n
13
13
A
n
14
14
A
n
15
15
A
n
16
16
A
n
17
17
A
n
18
18
A
n
19
19
A
n
20
20
A
n
21
21
A
n
22
22
A
PHE
23
n
23
PHE
23
A
ASN
24
n
24
ASN
24
A
LYS
25
n
25
LYS
25
A
ILE
26
n
26
ILE
26
A
THR
27
n
27
THR
27
A
PRO
28
n
28
PRO
28
A
ASN
29
n
29
ASN
29
A
LEU
30
n
30
LEU
30
A
ALA
31
n
31
ALA
31
A
GLU
32
n
32
GLU
32
A
PHE
33
n
33
PHE
33
A
ALA
34
n
34
ALA
34
A
PHE
35
n
35
PHE
35
A
SER
36
n
36
SER
36
A
LEU
37
n
37
LEU
37
A
TYR
38
n
38
TYR
38
A
ARG
39
n
39
ARG
39
A
GLN
40
n
40
GLN
40
A
LEU
41
n
41
LEU
41
A
ALA
42
n
42
ALA
42
A
HIS
43
n
43
HIS
43
A
GLN
44
n
44
GLN
44
A
SER
45
n
45
SER
45
A
ASN
46
n
46
ASN
46
A
SER
47
n
47
SER
47
A
THR
48
n
48
THR
48
A
ASN
49
n
49
ASN
49
A
ILE
50
n
50
ILE
50
A
LEU
51
n
51
LEU
51
A
PHE
52
n
52
PHE
52
A
SER
53
n
53
SER
53
A
PRO
54
n
54
PRO
54
A
VAL
55
n
55
VAL
55
A
SER
56
n
56
SER
56
A
ILE
57
n
57
ILE
57
A
ALA
58
n
58
ALA
58
A
THR
59
n
59
THR
59
A
ALA
60
n
60
ALA
60
A
PHE
61
n
61
PHE
61
A
ALA
62
n
62
ALA
62
A
MET
63
n
63
MET
63
A
LEU
64
n
64
LEU
64
A
SER
65
n
65
SER
65
A
LEU
66
n
66
LEU
66
A
GLY
67
n
67
GLY
67
A
THR
68
n
68
THR
68
A
LYS
69
n
69
LYS
69
A
ALA
70
n
70
ALA
70
A
ASP
71
n
71
ASP
71
A
THR
72
n
72
THR
72
A
HIS
73
n
73
HIS
73
A
ASP
74
n
74
ASP
74
A
GLU
75
n
75
GLU
75
A
ILE
76
n
76
ILE
76
A
LEU
77
n
77
LEU
77
A
GLU
78
n
78
GLU
78
A
GLY
79
n
79
GLY
79
A
LEU
80
n
80
LEU
80
A
ASN
81
n
81
ASN
81
A
PHE
82
n
82
PHE
82
A
ASN
83
n
83
ASN
83
A
LEU
84
n
84
LEU
84
A
THR
85
n
85
THR
85
A
GLU
86
n
86
GLU
86
A
ILE
87
n
87
ILE
87
A
PRO
88
n
88
PRO
88
A
GLU
89
n
89
GLU
89
A
ALA
90
n
90
ALA
90
A
GLN
91
n
91
GLN
91
A
ILE
92
n
92
ILE
92
A
HIS
93
n
93
HIS
93
A
GLU
94
n
94
GLU
94
A
GLY
95
n
95
GLY
95
A
PHE
96
n
96
PHE
96
A
GLN
97
n
97
GLN
97
A
GLU
98
n
98
GLU
98
A
LEU
99
n
99
LEU
99
A
LEU
100
n
100
LEU
100
A
ARG
101
n
101
ARG
101
A
THR
102
n
102
THR
102
A
LEU
103
n
103
LEU
103
A
ASN
104
n
104
ASN
104
A
GLN
105
n
105
GLN
105
A
PRO
106
n
106
PRO
106
A
ASP
107
n
107
ASP
107
A
SER
108
n
108
SER
108
A
GLN
109
n
109
GLN
109
A
LEU
110
n
110
LEU
110
A
GLN
111
n
111
GLN
111
A
LEU
112
n
112
LEU
112
A
THR
113
n
113
THR
113
A
THR
114
n
114
THR
114
A
GLY
115
n
115
GLY
115
A
ASN
116
n
116
ASN
116
A
GLY
117
n
117
GLY
117
A
LEU
118
n
118
LEU
118
A
PHE
119
n
119
PHE
119
A
LEU
120
n
120
LEU
120
A
SER
121
n
121
SER
121
A
GLU
122
n
122
GLU
122
A
GLY
123
n
123
GLY
123
A
LEU
124
n
124
LEU
124
A
LYS
125
n
125
LYS
125
A
LEU
126
n
126
LEU
126
A
VAL
127
n
127
VAL
127
A
ASP
128
n
128
ASP
128
A
LYS
129
n
129
LYS
129
A
PHE
130
n
130
PHE
130
A
LEU
131
n
131
LEU
131
A
GLU
132
n
132
GLU
132
A
ASP
133
n
133
ASP
133
A
VAL
134
n
134
VAL
134
A
LYS
135
n
135
LYS
135
A
LYS
136
n
136
LYS
136
A
LEU
137
n
137
LEU
137
A
TYR
138
n
138
TYR
138
A
HIS
139
n
139
HIS
139
A
SER
140
n
140
SER
140
A
GLU
141
n
141
GLU
141
A
ALA
142
n
142
ALA
142
A
PHE
143
n
143
PHE
143
A
THR
144
n
144
THR
144
A
VAL
145
n
145
VAL
145
A
ASN
146
n
146
ASN
146
A
PHE
147
n
147
PHE
147
A
GLY
148
n
148
GLY
148
A
ASP
149
n
149
ASP
149
A
THR
150
n
150
THR
150
A
GLU
151
n
151
GLU
151
A
GLU
152
n
152
GLU
152
A
ALA
153
n
153
ALA
153
A
LYS
154
n
154
LYS
154
A
LYS
155
n
155
LYS
155
A
GLN
156
n
156
GLN
156
A
ILE
157
n
157
ILE
157
A
ASN
158
n
158
ASN
158
A
ASP
159
n
159
ASP
159
A
TYR
160
n
160
TYR
160
A
VAL
161
n
161
VAL
161
A
GLU
162
n
162
GLU
162
A
LYS
163
n
163
LYS
163
A
GLY
164
n
164
GLY
164
A
THR
165
n
165
THR
165
A
GLN
166
n
166
GLN
166
A
GLY
167
n
167
GLY
167
A
LYS
168
n
168
LYS
168
A
ILE
169
n
169
ILE
169
A
VAL
170
n
170
VAL
170
A
ASP
171
n
171
ASP
171
A
LEU
172
n
172
LEU
172
A
VAL
173
n
173
VAL
173
A
LYS
174
n
174
LYS
174
A
GLU
175
n
175
GLU
175
A
LEU
176
n
176
LEU
176
A
ASP
177
n
177
ASP
177
A
ARG
178
n
178
ARG
178
A
ASP
179
n
179
ASP
179
A
THR
180
n
180
THR
180
A
VAL
181
n
181
VAL
181
A
PHE
182
n
182
PHE
182
A
ALA
183
n
183
ALA
183
A
LEU
184
n
184
LEU
184
A
VAL
185
n
185
VAL
185
A
ASN
186
n
186
ASN
186
A
TYR
187
n
187
TYR
187
A
ILE
188
n
188
ILE
188
A
PHE
189
n
189
PHE
189
A
PHE
190
n
190
PHE
190
A
LYS
191
n
191
LYS
191
A
GLY
192
n
192
GLY
192
A
LYS
193
n
193
LYS
193
A
TRP
194
n
194
TRP
194
A
GLU
195
n
195
GLU
195
A
ARG
196
n
196
ARG
196
A
PRO
197
n
197
PRO
197
A
PHE
198
n
198
PHE
198
A
GLU
199
n
199
GLU
199
A
VAL
200
n
200
VAL
200
A
LYS
201
n
201
LYS
201
A
ASP
202
n
202
ASP
202
A
THR
203
n
203
THR
203
A
GLU
204
n
204
GLU
204
A
GLU
205
n
205
GLU
205
A
GLU
206
n
206
GLU
206
A
ASP
207
n
207
ASP
207
A
PHE
208
n
208
PHE
208
A
HIS
209
n
209
HIS
209
A
VAL
210
n
210
VAL
210
A
ASP
211
n
211
ASP
211
A
GLN
212
n
212
GLN
212
A
VAL
213
n
213
VAL
213
A
THR
214
n
214
THR
214
A
THR
215
n
215
THR
215
A
VAL
216
n
216
VAL
216
A
LYS
217
n
217
LYS
217
A
VAL
218
n
218
VAL
218
A
PRO
219
n
219
PRO
219
A
MET
220
n
220
MET
220
A
MET
221
n
221
MET
221
A
LYS
222
n
222
LYS
222
A
ARG
223
n
223
ARG
223
A
LEU
224
n
224
LEU
224
A
GLY
225
n
225
GLY
225
A
MET
226
n
226
MET
226
A
PHE
227
n
227
PHE
227
A
ASN
228
n
228
ASN
228
A
ILE
229
n
229
ILE
229
A
GLN
230
n
230
GLN
230
A
HIS
231
n
231
HIS
231
A
SCS
232
n
232
SCS
232
A
LYS
233
n
233
LYS
233
A
LYS
234
n
234
LYS
234
A
LEU
235
n
235
LEU
235
A
SER
236
n
236
SER
236
A
SER
237
n
237
SER
237
A
TRP
238
n
238
TRP
238
A
VAL
239
n
239
VAL
239
A
LEU
240
n
240
LEU
240
A
LEU
241
n
241
LEU
241
A
MET
242
n
242
MET
242
A
LYS
243
n
243
LYS
243
A
TYR
244
n
244
TYR
244
A
LEU
245
n
245
LEU
245
A
GLY
246
n
246
GLY
246
A
ASN
247
n
247
ASN
247
A
ALA
248
n
248
ALA
248
A
THR
249
n
249
THR
249
A
ALA
250
n
250
ALA
250
A
ILE
251
n
251
ILE
251
A
PHE
252
n
252
PHE
252
A
PHE
253
n
253
PHE
253
A
LEU
254
n
254
LEU
254
A
PRO
255
n
255
PRO
255
A
ASP
256
n
256
ASP
256
A
GLU
257
n
257
GLU
257
A
GLY
258
n
258
GLY
258
A
LYS
259
n
259
LYS
259
A
LEU
260
n
260
LEU
260
A
GLN
261
n
261
GLN
261
A
HIS
262
n
262
HIS
262
A
LEU
263
n
263
LEU
263
A
GLU
264
n
264
GLU
264
A
ASN
265
n
265
ASN
265
A
GLU
266
n
266
GLU
266
A
LEU
267
n
267
LEU
267
A
THR
268
n
268
THR
268
A
HIS
269
n
269
HIS
269
A
ASP
270
n
270
ASP
270
A
ILE
271
n
271
ILE
271
A
ILE
272
n
272
ILE
272
A
THR
273
n
273
THR
273
A
LYS
274
n
274
LYS
274
A
PHE
275
n
275
PHE
275
A
LEU
276
n
276
LEU
276
A
GLU
277
n
277
GLU
277
A
ASN
278
n
278
ASN
278
A
GLU
279
n
279
GLU
279
A
ASP
280
n
280
ASP
280
A
ARG
281
n
281
ARG
281
A
ARG
282
n
282
ARG
282
A
SER
283
n
283
SER
283
A
ALA
284
n
284
ALA
284
A
SER
285
n
285
SER
285
A
LEU
286
n
286
LEU
286
A
HIS
287
n
287
HIS
287
A
LEU
288
n
288
LEU
288
A
PRO
289
n
289
PRO
289
A
LYS
290
n
290
LYS
290
A
LEU
291
n
291
LEU
291
A
SER
292
n
292
SER
292
A
ILE
293
n
293
ILE
293
A
THR
294
n
294
THR
294
A
GLY
295
n
295
GLY
295
A
THR
296
n
296
THR
296
A
TYR
297
n
297
TYR
297
A
ASP
298
n
298
ASP
298
A
LEU
299
n
299
LEU
299
A
LYS
300
n
300
LYS
300
A
SER
301
n
301
SER
301
A
VAL
302
n
302
VAL
302
A
LEU
303
n
303
LEU
303
A
GLY
304
n
304
GLY
304
A
GLN
305
n
305
GLN
305
A
LEU
306
n
306
LEU
306
A
GLY
307
n
307
GLY
307
A
ILE
308
n
308
ILE
308
A
THR
309
n
309
THR
309
A
LYS
310
n
310
LYS
310
A
VAL
311
n
311
VAL
311
A
PHE
312
n
312
PHE
312
A
SER
313
n
313
SER
313
A
ASN
314
n
314
ASN
314
A
GLY
315
n
315
GLY
315
A
ALA
316
n
316
ALA
316
A
ASP
317
n
317
ASP
317
A
LEU
318
n
318
LEU
318
A
SER
319
n
319
SER
319
A
GLY
320
n
320
GLY
320
A
VAL
321
n
321
VAL
321
A
THR
322
n
322
THR
322
A
GLU
323
n
323
GLU
323
A
GLU
324
n
324
GLU
324
A
ALA
325
n
325
ALA
325
A
PRO
326
n
326
PRO
326
A
LEU
327
n
327
LEU
327
A
LYS
328
n
328
LYS
328
A
LEU
329
n
329
LEU
329
A
SER
330
n
330
SER
330
A
LYS
331
n
331
LYS
331
A
ALA
332
n
332
ALA
332
A
VAL
333
n
333
VAL
333
A
HIS
334
n
334
HIS
334
A
LYS
335
n
335
LYS
335
A
ALA
336
n
336
ALA
336
A
VAL
337
n
337
VAL
337
A
LEU
338
n
338
LEU
338
A
THR
339
n
339
THR
339
A
ILE
340
n
340
ILE
340
A
ASP
341
n
341
ASP
341
A
GLU
342
n
342
GLU
342
A
LYS
343
n
343
LYS
343
A
GLY
344
n
344
GLY
344
A
THR
345
n
345
THR
345
A
GLU
346
n
346
GLU
346
A
ALA
347
n
347
ALA
347
A
ALA
348
n
348
ALA
348
A
GLY
349
n
349
GLY
349
A
ALA
350
n
350
ALA
350
A
MET
351
n
351
MET
351
A
PHE
352
n
352
PHE
352
A
LEU
353
n
353
LEU
353
A
GLU
354
n
354
GLU
354
A
ALA
355
n
355
ALA
355
A
ILE
356
n
356
ILE
356
A
PRO
357
n
357
PRO
357
A
MET
358
n
358
MET
358
A
SER
359
n
359
SER
359
A
ILE
360
n
360
ILE
360
A
PRO
361
n
361
PRO
361
A
PRO
362
n
362
PRO
362
A
GLU
363
n
363
GLU
363
A
VAL
364
n
364
VAL
364
A
LYS
365
n
365
LYS
365
A
PHE
366
n
366
PHE
366
A
ASN
367
n
367
ASN
367
A
LYS
368
n
368
LYS
368
A
PRO
369
n
369
PRO
369
A
PHE
370
n
370
PHE
370
A
VAL
371
n
371
VAL
371
A
PHE
372
n
372
PHE
372
A
LEU
373
n
373
LEU
373
A
MET
374
n
374
MET
374
A
ILE
375
n
375
ILE
375
A
GLU
376
n
376
GLU
376
A
GLN
377
n
377
GLN
377
A
ASN
378
n
378
ASN
378
A
THR
379
n
379
THR
379
A
LYS
380
n
380
LYS
380
A
SER
381
n
381
SER
381
A
PRO
382
n
382
PRO
382
A
LEU
383
n
383
LEU
383
A
PHE
384
n
384
PHE
384
A
MET
385
n
385
MET
385
A
GLY
386
n
386
GLY
386
A
LYS
387
n
387
LYS
387
A
VAL
388
n
388
VAL
388
A
VAL
389
n
389
VAL
389
A
ASN
390
n
390
ASN
390
A
PRO
391
n
391
PRO
391
A
THR
392
n
392
THR
392
A
GLN
393
n
393
GLN
393
A
LYS
394
n
394
LYS
394
A
author_defined_assembly
1
monomeric
A
SCS
232
3-(ETHYLDISULFANYL)-L-ALANINE
A
SCS
232
CYS
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ILE
50
A
O
ILE
50
A
N
LYS
387
A
N
LYS
387
A
O
LEU
383
A
O
LEU
383
A
N
MET
374
A
N
MET
374
A
O
VAL
371
A
O
VAL
371
A
N
PHE
253
A
N
PHE
253
A
O
ALA
250
A
O
ALA
250
A
N
MET
242
A
N
MET
242
A
O
GLU
141
A
O
GLU
141
A
N
LEU
118
A
N
LEU
118
A
O
THR
113
A
O
THR
113
A
N
PHE
189
A
N
PHE
189
A
O
LEU
184
A
O
LEU
184
A
N
LYS
331
A
N
LYS
331
A
O
HIS
334
A
O
HIS
334
A
N
TYR
297
A
N
TYR
297
A
O
GLU
204
A
O
GLU
204
A
N
MET
220
A
N
MET
220
A
O
MET
221
A
O
MET
221
A
N
LEU
288
A
N
LEU
288
A
O
SER
285
A
O
SER
285
A
N
PRO
362
A
N
PRO
362
1
A
MET
1
A
MET
1
1
Y
1
A
ASP
2
A
ASP
2
1
Y
1
A
PRO
3
A
PRO
3
1
Y
1
A
GLN
4
A
GLN
4
1
Y
1
A
GLY
5
A
GLY
5
1
Y
1
A
ASP
6
A
ASP
6
1
Y
1
A
ALA
7
A
ALA
7
1
Y
1
A
ALA
8
A
ALA
8
1
Y
1
A
GLN
9
A
GLN
9
1
Y
1
A
LYS
10
A
LYS
10
1
Y
1
A
THR
11
A
THR
11
1
Y
1
A
ASP
12
A
ASP
12
1
Y
1
A
THR
13
A
THR
13
1
Y
1
A
SER
14
A
SER
14
1
Y
1
A
HIS
15
A
HIS
15
1
Y
1
A
HIS
16
A
HIS
16
1
Y
1
A
ASP
17
A
ASP
17
1
Y
1
A
GLN
18
A
GLN
18
1
Y
1
A
ASP
19
A
ASP
19
1
Y
1
A
HIS
20
A
HIS
20
1
Y
1
A
PRO
21
A
PRO
21
1
Y
1
A
THR
22
A
THR
22
1
Y
1
A
PRO
106
A
PRO
106
0
Y
1
A
ASP
107
A
ASP
107
0
Y
1
A
SER
108
A
SER
108
0
Y
1
A
LYS
25
-146.43
-50.65
1
A
GLN
44
-45.42
-73.77
1
A
SER
47
-115.51
56.24
1
A
ALA
70
47.92
-146.37
1
A
PRO
106
-63.73
-155.45
1
A
SER
108
165.45
142.12
1
A
GLN
111
-56.90
105.96
1
A
LYS
136
-68.35
-77.48
1
A
HIS
139
39.74
41.83
1
A
ASP
149
-106.37
78.64
1
A
ASP
171
34.99
69.49
1
A
LYS
191
-163.49
76.34
1
A
HIS
209
-67.35
99.14
1
A
ASN
247
-165.51
28.20
1
A
ASP
256
-63.27
-176.72
1
A
LEU
318
-109.36
45.00
1
A
ASP
341
-147.58
-157.85
1
A
LYS
343
169.67
98.86
1
A
ALA
347
-149.07
-158.26
1
A
ALA
348
-53.91
87.83
1
A
ALA
350
56.59
100.94
1
A
SER
359
-179.15
140.22
1
A
ILE
360
-53.90
101.97
RESIDUES 106 - 108 ARE POORLY ORDERED. ALTHOUGH SOME
CONNECTED DENSITY EXISTS, A STEREOCHEMICALLY CORRECT
MODEL FITTING THE DATA COULD NOT BE BUILT. THE
OCCUPANCIES OF THESE RESIDUES ARE SET TO ZERO.
PRO 106 - SER 108 IS A POORLY ORDERED LOOP, PRESENT IN
MULTIPLE CONFORMATIONS. A STEREOCHEMICALLY VALID MODEL WAS
BUILT, BUT THE OCCUPANCIES ARE SET TO ZERO.
0.288
0.218
0.218
2.92
6.00
6699
91.7
1
0.000
MOLECULAR REPLACEMENT
CLEAVED ALPHA1-ANTITRYPSIN (PDB ENTRY 9API)
2.92
6.00
0
2956
0
0
2956
0.005
1.53
15.76
2.920
19.500
1PSI
7651
3.500
0.11400
0.11400
1
8.3600
2.200
91.7
0.204
2.91
3.11
4.000
0.204
2.00
74.4
model building
X-PLOR
refinement
X-PLOR
data reduction
MOSFLM
data scaling
CCP4
(SCALA)
phasing
X-PLOR
Intact recombined alpha1-antitrypsin mutant PHE 51 to LEU
1
N
N
A
THR
27
A
THR
27
HELX_P
A
GLN
44
A
GLN
44
1
1
18
A
PRO
54
A
PRO
54
HELX_P
A
GLY
67
A
GLY
67
1
2
14
A
ALA
70
A
ALA
70
HELX_P
A
GLY
79
A
GLY
79
1
3
10
A
GLU
89
A
GLU
89
HELX_P
A
ASN
104
A
ASN
104
1
4
16
A
ASP
128
A
ASP
128
HELX_P
A
LYS
135
A
LYS
135
1
5
8
A
THR
150
A
THR
150
HELX_P
A
GLY
164
A
GLY
164
1
6
15
A
VAL
200
A
VAL
200
HELX_P
A
ASP
202
A
ASP
202
5
7
3
A
LEU
260
A
LEU
260
HELX_P
A
GLU
266
A
GLU
266
1
8
7
A
HIS
269
A
HIS
269
HELX_P
A
LEU
276
A
LEU
276
1
9
8
A
LEU
299
A
LEU
299
HELX_P
A
GLN
305
A
GLN
305
1
10
7
A
LYS
310
A
LYS
310
HELX_P
A
PHE
312
A
PHE
312
5
11
3
covale
1.323
both
A
HIS
231
A
C
HIS
231
1_555
A
SCS
232
A
N
SCS
232
1_555
covale
1.325
both
A
SCS
232
A
C
SCS
232
1_555
A
LYS
233
A
N
LYS
233
1_555
SERINE PROTEASE INHIBITOR
SERPIN, SERINE PROTEASE INHIBITOR, GLYCOPROTEIN, POLYMORPHISM, EMPHYSEMA, DISEASE MUTATION, ACUTE PHASE
A1AT_HUMAN
UNP
1
1
P01009
MPSSVSWGILLLAGLCCLVPVSLAEDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVS
IATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKK
LYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTV
KVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGT
YDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIE
QNTKSPLFMGKVVNPTQK
26
418
1PSI
2
394
P01009
A
1
2
394
1
PHE
engineered mutation
LEU
51
1PSI
A
P01009
UNP
75
51
5
5
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
parallel
A
ILE
50
A
ILE
50
A
PHE
52
A
PHE
52
A
PRO
382
A
PRO
382
A
VAL
388
A
VAL
388
A
PHE
370
A
PHE
370
A
GLU
376
A
GLU
376
A
ALA
248
A
ALA
248
A
PRO
255
A
PRO
255
A
SER
237
A
SER
237
A
LYS
243
A
LYS
243
A
GLU
141
A
GLU
141
A
VAL
145
A
VAL
145
A
LEU
112
A
LEU
112
A
SER
121
A
SER
121
A
PHE
182
A
PHE
182
A
PHE
190
A
PHE
190
A
LYS
331
A
LYS
331
A
ILE
340
A
ILE
340
A
LEU
291
A
LEU
291
A
ASP
298
A
ASP
298
A
GLU
204
A
GLU
204
A
HIS
209
A
HIS
209
A
THR
215
A
THR
215
A
PHE
227
A
PHE
227
A
ARG
282
A
ARG
282
A
PRO
289
A
PRO
289
A
PRO
362
A
PRO
362
A
PHE
366
A
PHE
366
5
C 1 2 1